Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested Capital

AIM ImmunoTech (AIM) EBITDA Margin (2018 - 2023)

Historic EBITDA Margin for ImmunoTech (AIM) over the last 6 years, with Q4 2023 value amounting to 21544.62%.

  • ImmunoTech's EBITDA Margin changed N/A to 21544.62% in Q4 2023 from the same period last year, while for Dec 2023 it was 25986.49%, marking a year-over-year change of. This contributed to the annual value of 11630.59% for FY2024, which is 41694100.0% up from last year.
  • Latest data reveals that ImmunoTech reported EBITDA Margin of 21544.62% as of Q4 2023.
  • ImmunoTech's 5-year EBITDA Margin high stood at 8257.5% for Q2 2020, and its period low was 21544.62% during Q4 2023.